XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Business Combination - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
May 24, 2022
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Business Acquisition [Line Items]        
Goodwill, adjustments     $ 7,772  
Antares Pharma, Inc        
Business Acquisition [Line Items]        
Consideration transferred $ 1,045,700      
Consideration transferred, cash paid per acquiree share (in usd per share) $ 5.60      
Goodwill, adjustments     7,800  
Business combination, adjustment, accrued expense     2,000  
Business combination, adjustment, deferred tax liabilities, net     5,600  
Business combination, adjustment, accounts receivable     200  
Pro forma revenue of acquiree since acquisition date   $ 50,400 $ 69,100 $ 75,300
Proforma earnings or loss of acquiree since acquisition date       $ 35,500